Trimetazidine – Cardiology MCQ
Trimetazidine is an antianginal agent which acts by inhibition of:
A. Beta oxidation of fatty acids
B. Anaerobic metabolism of glucose
C. Calcium channels
D. Beta adrenergic receptors
Please check the YouTube video above for discussion
Related Posts
-
Survival after CABG – Cardiology MCQ
No Comments | Nov 12, 2015 -
AV node independent tachycardia – Cardiology MCQ
No Comments | Oct 20, 2014 -
Cardiology MCQ – Type of respiratory failure in shock
2 Comments | Dec 20, 2019
-
Probe patent foramen ovale – Cardiology MCQ
No Comments | Nov 2, 2013
About The Author
Johnson Francis
Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal